Title |
Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs!
|
---|---|
Published in |
European Journal of Clinical Pharmacology, April 2013
|
DOI | 10.1007/s00228-013-1506-8 |
Pubmed ID | |
Authors |
François Montastruc, Virginie Gardette, Christelle Cantet, Antoine Piau, Maryse Lapeyre-Mestre, Bruno Vellas, Jean-Louis Montastruc, Sandrine Andrieu, REAL.FR Group |
Abstract |
Few studies have investigated potentially inappropriate medication (PIM) use in patients with Alzheimer's disease (AD). The aim of our study was to assess the prevalence of PIM in community-dwelling patients diagnosed with mild-to-moderate AD and identify the clinical factors associated with PIM prescriptions. |
Mendeley readers
The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 2 | 2% |
France | 1 | 1% |
Unknown | 80 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 11 | 13% |
Student > Bachelor | 11 | 13% |
Student > Ph. D. Student | 8 | 10% |
Student > Postgraduate | 7 | 8% |
Student > Master | 7 | 8% |
Other | 20 | 24% |
Unknown | 19 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 20 | 24% |
Pharmacology, Toxicology and Pharmaceutical Science | 15 | 18% |
Nursing and Health Professions | 6 | 7% |
Chemistry | 4 | 5% |
Agricultural and Biological Sciences | 2 | 2% |
Other | 10 | 12% |
Unknown | 26 | 31% |